References
- Wang F, Wen T, Chen XY, Wu H. Protective effects of pirfenidone on D-galactosamine and lipopolysaccharide-induced acute hepatotoxicity in rats. Inflamm Res 2008;57:183–8.
- Grattendick KJ, Nakashima JM, Feng L, et al. Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitro. Int Immunopharmacol 2008;8:679–87.
- Dosanjh A. A review of nutritional problems and the cystic fibrosis lung transplant patient. Pediatr Transplant 2002;6:388–91.
- Burghardt I, Tritschler F, Opitz CA, et al. Pirfenidone inhibits TGF-beta expression in malignant glioma cells. Biochem Biophys Res Commun 2007;354:542–7.
- Chowdhury S, Guha R, Trivedi R, et al. Pirfenidone nanoparticles improve corneal wound healing and prevent scarring following alkali burn. PLoS One 2013;8:e70528.
- Zhong H, Sun G, Lin X, et al. Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. Invest Ophthalmol Vis Sci 2011;52:3136–42.
- Sun G, Lin X, Zhong H, et al. Pharmacokinetics of pirfenidone after topical administration in rabbit eye. Mol Vis 2011;17:2191–6.
- Sieg JW, Robinson JR. Mechanistic studies on transcorneal permeation of pilocarpine. J Pharm Sci 1976;65:1816–22.
- Schoenwald RD, Smolen VF. Drug-absorption analysis from pharmacological data. II. Transcorneal biophasic availability of tropicamide. J Pharm Sci 1971;60:1039–45.
- Gupta S, Vyas SP. Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate. Sci Pharm 2010;78:959–76.
- Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Drug Dev Ind Pharm 2013;39:1599–617.
- Wilhelmus KR. The Draize eye test. Surv Ophthalmol 2001;45:493–515.
- Wu C, Qi H, Chen W, et al. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin. Yakugaku Zasshi 2007;127:183–91.
- Kumar S, Himmelstein KJ. Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose. J Pharm Sci 1995;84:344–8.
- Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release 2001;73:205–11.
- Tashakori-Sabzevar F, Mohajeri SA. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses. Drug Dev Ind Pharm 2015;41:703–13.